Oclacitinib impurity 5 CAS CATO-C4X-30185

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-30185
Molecular FormulaC28H32N4O5S2
Molecular Weight568.71 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Oclacitinib impurity 5 CAS CATO-C4X-30185 chemical structure

Description

Structurally, Oclacitinib impurity 5 (C28H32N4O5S2) contains a steroid core, an amide group, a sulfone group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 15.0, corresponding to approximately 15 ring(s) or double-bond equivalent(s). With a molecular weight of 568.71 g/mol, it falls into the moderately-high-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

CATO supplies Oclacitinib impurity 5 (CAS CATO-C4X-30185), a pharmacopoeial impurity reference standard (molecular formula C28H32N4O5S2, MW 568.71 g/mol) used for the identification and quantification of trace impurities in APIs.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Oclacitinib impurity 5 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC28H32N4O5S2
Molecular Weight568.71 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)15.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
Nitrogen Atoms4
Sulfur Atoms2

Related Oclacitinib Standards

Recommended Standards

Why CATO?